Saturn V Capital Management LP Diversified Active

CIK: 0001964437 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value ($000): $255,367 (100.0% shares, 0.0% debt)

Holdings (24)

IRON DISC MEDICINE INC 12.6%
Value ($000) $32,296 Shares 509,406 Est. Cost $47.84 Unrealized +20.9%
ASND ASCENDIS PHARMA A/S 10.7%
Value ($000) $27,393 Shares 198,977 Est. Cost $128.89 Unrealized
MLTX MOONLAKE IMMUNOTHERAPEUTICS 7.3%
Value ($000) $18,742 Shares 346,111 Est. Cost $47.43 Unrealized +7.6%
CGON CG ONCOLOGY INC 6.7%
Value ($000) $17,015 Shares 593,262 Est. Cost $34.95 Unrealized -2.1%
PCVX VAXCYTE INC 6.5%
Value ($000) $16,723 Shares 204,285 Est. Cost $69.08 Unrealized +43.7%
CYTK CYTOKINETICS INC 6.4%
Value ($000) $16,387 Shares 348,364 Est. Cost $43.27 Unrealized +20.0%
CARGO THERAPEUTICS INC 5.7%
Value ($000) $14,531 Shares 1,007,677 Est. Cost $16.71 Unrealized
CELC CELCUITY INC 5.5%
Value ($000) $13,925 Shares 1,063,783 Est. Cost $16.40 Unrealized -13.9%
SNDX SYNDAX PHARMACEUTICALS INC 5.1%
Value ($000) $13,068 Shares 988,528 Est. Cost $18.38 Unrealized -6.9%
XENE XENON PHARMACEUTICALS INC 5.0%
Value ($000) $12,641 Shares 322,470 Est. Cost $41.35 Unrealized 0.0%
ARGX ARGENX SE 4.8%
Value ($000) $12,149 Shares 19,754 Est. Cost $394.09 Unrealized
COGT COGENT BIOSCIENCES INC 4.6%
Value ($000) $11,688 Shares 1,498,425 Est. Cost $8.73 Unrealized +14.2%
MERUS N V 3.9%
Value ($000) $9,866 Shares 234,637 Est. Cost $33.69 Unrealized
CTNM CONTINEUM THERAPEUTICS INC 3.3%
Value ($000) $8,395 Shares 573,022 Est. Cost $15.90 Unrealized -0.4%
ABVX ABIVAX SA 1.9%
Value ($000) $4,780 Shares 653,071 Est. Cost $14.21 Unrealized
KALV KALVISTA PHARMACEUTICALS INC 1.8%
Value ($000) $4,713 Shares 556,489 Est. Cost $7.51 Unrealized +37.9%
INOZYME PHARMA INC 1.5%
Value ($000) $3,808 Shares 1,374,582 Est. Cost $4.59 Unrealized
IRWD IRONWOOD PHARMACEUTICALS INC 1.4%
Value ($000) $3,608 Shares 814,533 Est. Cost $11.37 Unrealized -64.3%
AMLX AMYLYX PHARMACEUTICALS INC 1.3%
Value ($000) $3,361 Shares 889,073 Est. Cost $4.71 Unrealized 0.0%
CRNX CRINETICS PHARMACEUTICALS IN 1.2%
Value ($000) $3,023 Shares 59,125 Est. Cost $18.62 Unrealized +200.5%
SLN SILENCE THERAPEUTICS PLC 1.1%
Value ($000) $2,718 Shares 395,024 Est. Cost $18.18 Unrealized
NAMS NEWAMSTERDAM PHARMA COMPANY 1.0%
Value ($000) $2,570 Shares 100,000 Est. Cost $21.24 Unrealized 0.0%
OCUL OCULAR THERAPEUTIX INC 0.6%
Value ($000) $1,635 Shares 191,456 Est. Cost $9.76 Unrealized 0.0%
MBX MBX BIOSCIENCES INC 0.1%
Value ($000) $332 Shares 18,000 Est. Cost $21.31 Unrealized 0.0%